Samuel T. Gilkeson AssociateSheppard, Mullin, Richter & Hampton LLPWebsitewww.sheppardmullin.comOrganization ProfileFull ProfileConnectEmail424-288-5304 Professional Biography Samuel T. Gilkeson IV is an associate in the Corporate Practice Group in the firm's Century City office and is a member of the firm’s Healthcare Team. Education J.D., Pepperdine University, 2017 B.A., West Virginia University, 2012 More Legal and Business Bylines From Samuel T. Gilkeson What’s in the Bottle? FDA Announces New Blockchain Pilot Program for Tracking Drug Distribution - (Posted On Friday, July 12, 2019) Blockchain and Healthcare Innovation: A City, Academia, and Technology Firms Join Forces to find Blockchain Solutions to Address Public Health Challenges - (Posted On Friday, June 14, 2019) Recent Activity in Medicare Audit Programs: CMS Announces Increase in Audit Contractor Oversight - (Posted On Thursday, May 30, 2019) Arkansas and Kentucky Halt Medicaid Work Requirements - (Posted On Friday, April 26, 2019) The Synaptic Health Alliance: A Look at How Blockchain Technology Could Improve Provider Data Quality - (Posted On Thursday, January 31, 2019) Midterms Bring New Focus to Healthcare - (Posted On Monday, November 12, 2018) More Than 700 CEOs of Hospitals and Health Systems Write to Congress to Stop Cuts to the 340B Drug Pricing Program - (Posted On Wednesday, October 10, 2018) The Risk Corridor is Closed: Insurers Seek Recourse in the Federal Circuit - (Posted On Friday, August 10, 2018) The Trump Administration Allows for Longer “Short-Term” Health Insurance Policies, but Coverage Stays the Same - (Posted On Friday, August 03, 2018) No Longer in Suspense: CMS Issues Final Rule Announcing that Risk Adjustment Program Transfers for 2017 will be Distributed in September - (Posted On Friday, July 27, 2018) Pagination Page 1 Next page Next › Current Legal Analysis WELL THAT WAS NICE: Democratic FCC Commissioner “Welcome[s]” The Opportunity to Work with Olivia Trusty by: Eric J. Troutman Federal Circuit Says Proper Orange Book-Listed Patent Must Claim Active Ingredient by: Courtenay C. Brinckerhoff DORA Takes Effect: Key Next Steps for Firms by: Nathaniel W. Lalone , Ciara McBrien Will UK Business Face Supply Chain Challenges Now Trump is in Office? by: Rachael Markham , Matthew Kirk Latest PFAS Consumer Fraud Lawsuit Re-Raises Important Considerations For Companies by: John Gardella Dirty Steel-Toe Boots, Episode 26: OSHA’s Role During President Trump’s Second Term [Podcast] by: Phillip B. Russell , Dee Anna Hays PFAS Sewer Sludge Risks Exist Says EPA…But Will It Matter After Today? by: John Gardella New Year's Resolutions for Employment, Industrial Relations, and Work Health and Safety by: Stephen Hardy Upcoming Events Jan 21 2025 International Privacy & Cybersecurity Legal Update Jan 21 2025 U.S. Data Privacy & Cybersecurity Law Update Jan 21 2025 The Ethical Issues Involved with Creating a Data Protection Impact Assessment (DPIA) Jan 21 2025 U.S. Regulatory Investigations for Data Privacy and Cybersecurity Jan 22 2025 Employee Activism and the Issues It Can Create Jan 22 2025 The SEC under President Trump: A Preview Jan 22 2025 Transgender Employees and Related Issues in the Workplace Jan 28 2025 Antibody Drug Conjugates Keep Growing: What You Need to Know Print
